- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Vaccines: a promising therapy for myelodysplastic syndrome ; volume:17 ; number:1 ; day:8 ; month:1 ; year:2024 ; pages:1-17 ; date:12.2024
Journal of hematology & oncology ; 17, Heft 1 (8.1.2024), 1-17, 12.2024
- Creator
-
Gera, Kriti
Chauhan, Anjali
Castillo, Paul
Rahman, Maryam
Mathavan, Akash
Mathavan, Akshay
Oganda-Rivas, Elizabeth
Elliott, Leighton
Wingard, John R.
Sayour, Elias J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01523-4
- URN
-
urn:nbn:de:101:1-2024032209153299072022
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gera, Kriti
- Chauhan, Anjali
- Castillo, Paul
- Rahman, Maryam
- Mathavan, Akash
- Mathavan, Akshay
- Oganda-Rivas, Elizabeth
- Elliott, Leighton
- Wingard, John R.
- Sayour, Elias J.
- SpringerLink (Online service)
Other Objects (12)
New therapy options for myelodysplastic syndrome—all for all or targeted?
Epigenetic therapy in myelodysplastic syndromes
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome
The Evolving Landscape of Myelodysplastic Syndrome Prognostication
Genetic vaccines and therapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Relapsed Waldenstrom’s Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma
African swine fever vaccines: a promising work still in progress
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome
New therapy options for myelodysplastic syndrome—all for all or targeted?
Epigenetic therapy in myelodysplastic syndromes
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome
The Evolving Landscape of Myelodysplastic Syndrome Prognostication
Genetic vaccines and therapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Relapsed Waldenstrom’s Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma
African swine fever vaccines: a promising work still in progress
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome
New therapy options for myelodysplastic syndrome—all for all or targeted?
Epigenetic therapy in myelodysplastic syndromes
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome
The Evolving Landscape of Myelodysplastic Syndrome Prognostication
Genetic vaccines and therapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Relapsed Waldenstrom’s Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma
African swine fever vaccines: a promising work still in progress
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics